Position in BSX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,121,781
-$180,890 QoQ
Shares Held
17,877
+30.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Arax Advisory Partners holds $13,907,312 across 61 Medical Devices names. BSX ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
41,591 | $4,270,147 | |
| 2 | SYK |
Stryker Corp
|
7,835 | $2,574,502 | |
| 3 | ZBH |
Zimmer Biomet Holdings, Inc.
|
19,826 | $1,792,666 | |
| 4 | MDT |
Medtronic plc
|
15,381 | $1,332,763 | |
| 5 | BSX |
Boston Scientific Corp
This page
|
17,877 | $1,121,781 | |
| 6 | GMED |
Globus Medical Inc
|
3,793 | $326,804 | |
| 7 | DXCM |
Dexcom Inc
|
4,379 | $275,001 | |
| 8 | NVCR |
NovoCure Ltd
|
19,607 | $213,716 |
All Filings in BSX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,121,781 | 17,877 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,302,671 | 13,662 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,756,509 | 38,477 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $350,801 | 3,266 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $167,359 | 1,659 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $160,865 | 1,801 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $56,229 | 671 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $40,969 | 532 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $1,150 | 32 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||